Literature DB >> 3191108

Effects of the local anesthetic tetracaine on the structural and dynamic properties of lipids in model membranes: a high-pressure Fourier transform infrared study.

M Auger1, H C Jarrell, I C Smith, D J Siminovitch, H H Mantsch, P T Wong.   

Abstract

High-pressure Fourier transform infrared (FT-IR) spectroscopy was used to study the effects of a local anesthetic, tetracaine, on the structural and dynamic properties of lipids in model membranes. The model membrane systems studied were multilamellar aqueous dispersions of 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and 1,2-di-O-hexadecyl-sn-glycero-3-phosphocholine (DHPC) in the absence and presence of a physiological concentration of cholesterol (30 mol %). The infrared spectra were measured at 28 degrees C in a diamond anvil cell as a function of pressure up to 25 kbar. The results indicate that the effects of tetracaine on the structure of pure DMPC bilayers in the gel state are dependent on the state of charge of the anesthetic. The uncharged tetracaine disorders the lipid acyl chains while the charged form induces the formation of an interdigitated gel phase. The presence of cholesterol in the latter system prevents the formation of the interdigitated phase, whereas in the former system it disorders the lipid acyl chains in the gel state. Moreover, it is shown that the addition of uncharged tetracaine to interdigitated DHPC bilayers does not alter the interdigitated state of the hydrocarbon chains.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3191108     DOI: 10.1021/bi00416a038

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Effects of heterocyclic and tertiary permeant amines on the electron transfer in thylakoid membranes.

Authors:  Vera Opanasenko; Alexey Agafonov; Raissa Demidova
Journal:  Photosynth Res       Date:  2002       Impact factor: 3.573

2.  Pressure-induced correlation field splitting of vibrational modes: structural and dynamic properties in lipid bilayers and biomembranes.

Authors:  P T Wong
Journal:  Biophys J       Date:  1994-05       Impact factor: 4.033

3.  The osmoreactive betaine carrier BetP from Corynebacterium glutamicum is a sensor for cytoplasmic K+.

Authors:  R Rübenhagen; S Morbach; R Krämer
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

4.  High-throughput screening of drug-lipid membrane interactions via counter-propagating second harmonic generation imaging.

Authors:  Trang T Nguyen; John C Conboy
Journal:  Anal Chem       Date:  2011-07-06       Impact factor: 6.986

5.  Tetracaine-membrane interactions: effects of lipid composition and phase on drug partitioning, location, and ionization.

Authors:  Jingzhong Zhang; Theresa Hadlock; Alison Gent; Gary R Strichartz
Journal:  Biophys J       Date:  2007-03-09       Impact factor: 4.033

6.  Influence of the local anesthetic tetracaine on the phase behavior and the thermodynamic properties of phospholipid bilayers.

Authors:  M Böttner; R Winter
Journal:  Biophys J       Date:  1993-11       Impact factor: 4.033

7.  Label-free detection of drug-membrane association using ultraviolet-visible sum-frequency generation.

Authors:  Trang T Nguyen; Kelvin Rembert; John C Conboy
Journal:  J Am Chem Soc       Date:  2009-02-04       Impact factor: 15.419

8.  Triggering Glutamate Excretion in Corynebacterium glutamicum by Modulating the Membrane State with Local Anesthetics and Osmotic Gradients.

Authors:  C Lambert; A Erdmann; M Eikmanns; R Kramer
Journal:  Appl Environ Microbiol       Date:  1995-12       Impact factor: 4.792

9.  Site of action of the local anesthetic tetracaine in a phosphatidylcholine bilayer with incorporated cardiolipin.

Authors:  A Shibata; K Ikawa; H Terada
Journal:  Biophys J       Date:  1995-08       Impact factor: 4.033

10.  Compression of lipid membranes as observed at varying membrane positions.

Authors:  S F Scarlata
Journal:  Biophys J       Date:  1991-08       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.